Introduction
============

Fungal keratitis is a vision-threatening disease \[[@r1]\]. Often due to filamentous fungi in the tropics, corneal infection due to *Candida albicans* has a worldwide distribution \[[@r2]\]. Although linked to environmental exposure, especially in the setting of injury or keratopathy \[[@r3]\], the pathogenesis of fungal keratitis is not fully understood. Fungal virulence factors allow growth and invasion into the corneal stroma \[[@r4],[@r5]\], but host responses also contribute to the pathophysiology of corneal disease. Studies have recently shown that matrix metalloproteinases \[[@r6],[@r7]\] and other inflammatory mediators have key roles in the progression and outcome of keratomycosis. To gain further insight into the molecular processes of keratomycosis, this study investigated the global genetic expression pattern at the onset of *Candida albicans* keratitis.

Corneal infection by *Candida albicans* triggers an inflammatory response that leads to visual loss in more than half of affected eyes despite therapy \[[@r2]\]. The prompt inflammatory response consists predominantly of neutrophils \[[@r8]\], although lymphocytes and macrophages are also involved \[[@r9]\]. Our studies suggest that proinflammatory mediators play important roles at the onset of *Candida albicans* keratitis, but the early molecular events that are involved in the corneal and immune responses remain unclear. Therefore, we examined the early transcriptional profile of the fungus-infected cornea in comparison to controls. Observed changes in the corneal transcriptome were categorized to suggest potentially important pathways contributing to corneal inflammation during fungal keratitis.

Gene microarray methodology has evolved as an important technique to investigate the mechanisms for many ocular disorders including microbial keratitis \[[@r10],[@r11]\]. In this study, we systematically evaluated the host gene expression during the early stage of *Candida albicans* keratitis in a mouse model. To identify molecular cascades of potential importance in pathogenesis, we compared corneas of mice that developed fungal keratitis after epithelial scarification to uninfected, scarified controls. Results were validated for selected genes encoding interleukins and other cytokines.

Methods
=======

Experimental fungal keratitis
-----------------------------

A human isolate of *Candida albicans* strain SC5314 \[[@r12]\] was grown on Sabouraud dextrose agar (Difco, Detroit, MI) for three days at 25 °C. Yeasts were harvested and diluted in sterile phosphate-buffered saline (PBS) to yield 2×10^5^ colony-forming units (CFU)/μl \[[@r12]\]. Thirty adult, female BALB/c mice six- to eight-weeks old (Harlan Sprague-Dawley, Houston, TX) were anesthetized intraperitoneally with rodent combination anesthesia, and the corneas of right eyes were superficially scarified \[[@r13]\]. A 5 µl inoculum (1×10^6^ CFU) of *Candida albicans* was applied to the scarified cornea to induce experimental keratitis. An equivalent volume of sterile PBS diluent was applied to mock-infected controls. Animals were treated in accordance with the ARVO Statement for the Use of Animals in Ophthalmic and Vision Research, and protocols were approved by the Baylor College of Medicine Institutional Animal Care and Use Committee. The severity of keratomycosis was categorized at 24 h post-inoculation (p.i.) \[[@r13]\] when mice were sacrificed and right eyes enucleated.

RNA extraction
--------------

Mouse corneas were dissected at 24 h p.i., and surrounding tissues were removed. Corneas were pooled in sets of five for total RNA extraction with triplicate groups being prepared for *Candida albicans-*infected and mock-infected control groups. RNA was extracted from each pooled sample using RNeasy MicroKit (Qiagen, Valencia, CA), and samples were treated with DNase (Qiagen) and stored at −80 °C until use.

Microarray analysis
-------------------

Microarray analysis was performed in the Microarray Core Facility of Baylor College of Medicine (Houston, TX). RNA samples with acceptable spectrophotometric ratios (OD 260/280 ratios greater than 2.0 and 260/230 ratios greater than 1.5) and good electrophoretic profiles were used for microarray analysis. Affymetrix Genechip (Affymetrix, Santa Clara, CA) protocols were applied to qualified samples for two cycles of amplification. The double-stranded cDNA end product was processed with an in vitro transcription kit (Affymetirx) to produce biotin-labeled cRNA that was quantified with a ND-1000 spectrophotometer (NanoDrop Technologies, Wilmington, DE). Labeled cRNA (15 μg) was fragmented and rechecked for concentration. A hybridization mixture containing Affymetrix spike-in controls and fragmented labeled cRNA was hybridized overnight at 45 °C with rotation at 60 rpm then washed and stained with a streptavidin and R-phycoerythrin conjugate stain on a fluidics station 450 (Affymetrix). Following signal amplification with biotinylated antistreptavidin, stained arrays were scanned and recorded using Affymetrix GCOS software version 1.4 (Affymetrix) then adjusted and analyzed with [BioConductor](http://www.bioconductor.org) software \[[@r14]\]. Pairwise comparisons were made between infected and mock-infected control groups. Raw p values were adjusted by the Benjamini-Hochberg method for 5% false discovery rate to yield adjusted p values \[[@r15]\]. The criteria for significance of differentially regulated genes were established as greater than or equal to a twofold change with an adjusted p value of less than or equal to 0.05. Pathways were analyzed (Ingenuity Systems, Redwood City, CA) to determine the ratio of known genes within each pathway that were significantly upregulated during *Candidas albicans* keratitis relative to the total number of known genes.

Reverse transcription of RNA and quantitative real-time RT-PCR
--------------------------------------------------------------

Total RNA isolated from corneas one day after inoculation was spectrophotometrically quantified at 260 nm. The first-strand cDNA was synthesized from 0.4 μg of total RNA with Ready-To-Go You-Prime First-Strand Beads (GE Healthcare, Princeton, NJ) and random hexamers (Applied Biosystems, Foster City, CA). Real-time polymerase chain reaction (RT-PCR) was performed using TaqMan Assays ([Table 1](#t1){ref-type="table"}) and TaqMan Gene Expression Master Mix and Assays (Applied Biosystems). Primers specific for interleukins, *IL-1β*, *IL-6*, and *IL-23α*; chemokine ligands, *CCL4* and *CCL7*; chemokine receptors, *CCR3* and *CCR5*; and transforming growth factor-beta 2 (*TGF-β2*) gene transcripts (Applied Biosystems) were used to quantify gene expression levels. The threshold cycle (C~T~) for each target mRNA was normalized to glyceraldehyde-3-phosphate dehydrogenase (*GAPDH*) mRNA and averaged. Gene expression levels were calculated from normalized C~T~ results, and mean results were used to determine relative fold changes between experimental groups. Two-group comparisons were analyzed with Student's *t*-test. A p value less than or equal to 0.05 was considered statistically significant.

###### Oligonucleotide primers used for real-time RT--PCR.

  **Gene (Symbol)**                                    **Assay ID**    **Amplicon length**
  ---------------------------------------------------- --------------- ---------------------
  Interleukin 1 beta (*IL-1β*)                         Mm00434228_m1   90
  Interleukin 6 (*IL-6*)                               Mm00446191_m1   124
  Chemokine (C-C) ligand 4 (*CCL4*)                    Mm00443111_ml   70
  Chemokine (C-C) ligand 7 (*CCL7*)                    Mm00443113_ml   122
  Chemokine receptor 3 (*CCR3*)                        Mm01216172_m1   98
  Chemokine receptor 5 (*CCR5*)                        Mm01216171_ml   78
  Interleukin 23 alpha (*IL-23α*)                      Mm00518984_m1   61
  Transforming growth factor beta 2 (*TGF-β2*)         Mm01321739_m1   109
  Glyceraldehyde-3-phosphate dehydrogenase (*GAPDH*)   Mm99999915_gl   107

The assay ID is from Applied Biosystems.

Results
=======

Experimental post-traumatic keratomycosis
-----------------------------------------

All animals infected with *Candida albicans* strain SC5314 developed signs of keratitis by 24 h p.i. Mean±standard deviation (SD) disease severity scores of three independent *Candida albicans-*infected groups (five per group) were 8.0±0.7, 8.8±0.8, and 8.2±0.8. Based upon one-way ANOVA, no significant difference occurred among the three groups (p=0.27), and the overall mean ocular disease severity was 8.3±0.4. No clinical disease or obvious signs of infection was found in any eyes of the mock-infected control groups.

Corneal gene expression
-----------------------

Triplicate samples of RNA from five-cornea pools of infected and control, mock-infected groups met criteria for microarray analysis ([Table 2](#t2){ref-type="table"}). Overall, the scaling factor was less than or equal to 3 or within two SD around the mean, and the average background level was less than 100 for all samples. All three probes were present for both housekeeping genes coding for β-actin and GAPDH, and as expected, two probes were present for the spike-in probe sets, BioB, BioC, BioD, and CreX. RNA degradation plots demonstrated similar patterns for all chips (data not shown).

###### Results of RNA quality control evaluation.

  **Experimental group**   **Scaling factor**   **Average background**   **PCall %**   ***β-Actin* 3′to 5′ ratio**   ***GAPDH* 3′to 5′ ratio**
  ------------------------ -------------------- ------------------------ ------------- ----------------------------- ---------------------------
  Infected 1               2.5                  64.5                     56.9          2.6                           2.7
  Infected 2               2.5                  54.1                     54            2                             2.1
  Infected 3               2.4                  55.8                     52.4          1.8                           1.9
  Control 1                2.4                  60.6                     52.9          2.8                           2.6
  Control 2                2.4                  54.9                     53.7          3                             2.6
  Control 3                4.6                  53.7                     47.2          3.1                           2.8

Triplicate samples of five-cornea pools were used from *Candida albicans*-infected or mock-infected control animals. PCall % is the percent of probe sets that are called "present" by Affymetrix's algorithm. The 3′ to 5′ ratio is the 3′-end to 5′-end probe intensity ratio. The number of "present" probes for housekeeping probe sets (*β-actin* and *GAPDH*) was 3, and the number of spike-in probe sets (BioB, BioC, BioD, and CreX) was 2.

Among the total of 45,102 genes detected by the Affymetrix Genechip 430.2 microarray, 3,977 genes (8.82%) in *Candida albicans-*infected corneas were significantly (p≤0.05) and differentially (≥2.0 fold change) regulated compared to mock-infected control corneas. Of these, 1,987 genes were upregulated, and 1,990 were down-regulated. With a criterion of at least 4.0 fold significant change in the expression level, 1,672 genes (3.71%) were differentially expressed with 1,075 upregulated and 597 down-regulated. Thirty different genes were significantly upregulated more than 100 fold ([Table 3](#t3){ref-type="table"}). The frequency of significant gene expression followed a bell-shaped distribution ([Figure 1](#f1){ref-type="fig"}).

###### Categories of all genes significantly upregulated more than 100 fold.

  **Category**                           **Symbol**   **Description**                                              **GenBank accession**                                                               **Relative upregulation**   **p value**
  -------------------------------------- ------------ ------------------------------------------------------------ ----------------------------------------------------------------------------------- --------------------------- -------------
  Chemokines                             *PPBP*       Chemokine (C-X-C) ligand 7                                   [AB042817](http://www.ncbi.nlm.nih.gov/entrez/viewer.fcgi?db=nuccore&id=18253080)   834.4                       0.01
                                         *CCL3*       chemokine (C-C) ligand 3                                     [AA895994](http://www.ncbi.nlm.nih.gov/entrez/viewer.fcgi?db=nucest&id=3032387)     374.3                       0.04
                                         *CXCL3*      chemokine (C-X-C) ligand 3                                   [AK144158](http://www.ncbi.nlm.nih.gov/entrez/viewer.fcgi?db=nuccore&id=74184421)   291.7                       0.04
                                         *CCL4*       chemokine (C-C) ligand 4                                     [AF128218](http://www.ncbi.nlm.nih.gov/entrez/viewer.fcgi?db=nuccore&id=6652955)    145.2                       0.011
                                         *CXCL5*      chemokine (C-X-C) ligand 5                                   [AK044397](http://www.ncbi.nlm.nih.gov/entrez/viewer.fcgi?db=nuccore&id=26090334)   132.4                       0.05
  Metalloproteinases                     *MMP13*      matrix metallopeptidase 13                                   [AK150728](http://www.ncbi.nlm.nih.gov/entrez/viewer.fcgi?db=nuccore&id=74178021)   375.4                       0.001
                                         *ADAM8*      a disintegrin and metallopeptidase domain 8                  [AK089086](http://www.ncbi.nlm.nih.gov/entrez/viewer.fcgi?db=nuccore&id=26354229)   108                         0.01
                                         *MMP8*       matrix metallopeptidase 8                                    [AK089234](http://www.ncbi.nlm.nih.gov/entrez/viewer.fcgi?db=nuccore&id=26354353)   102.5                       0.0003
  Interleukin cytokines                  *IL-6*       interleukin 6                                                [AK089780](http://www.ncbi.nlm.nih.gov/entrez/viewer.fcgi?db=nuccore&id=26354666)   245.4                       0.009
                                         *IL-1β*      interleukin 1 beta                                           [AK156396](http://www.ncbi.nlm.nih.gov/entrez/viewer.fcgi?db=nuccore&id=74224153)   136.8                       0.03
                                         *OSM*        oncostatin M                                                 [AK087945](http://www.ncbi.nlm.nih.gov/entrez/viewer.fcgi?db=nuccore&id=26352845)   122.7                       0.006
  Leukocyte chemotaxis                   *FPR1*       formyl peptide receptor 1                                    [AK137714](http://www.ncbi.nlm.nih.gov/entrez/viewer.fcgi?db=nuccore&id=74200586)   145.2                       0.01
                                         *FPR-RS2*    formyl peptide receptor, related sequence 2                  [AF071180](http://www.ncbi.nlm.nih.gov/entrez/viewer.fcgi?db=nuccore&id=3549279)    132.8                       0.05
                                         *SELL*       selectin, lymphocyte                                         [AK137509](http://www.ncbi.nlm.nih.gov/entrez/viewer.fcgi?db=nuccore&id=74210396)   114.3                       0.01
  Leukocyte surface molecules            *CLEC4D*     C-type lectin domain family 4, member d                      [AF061272](http://www.ncbi.nlm.nih.gov/entrez/viewer.fcgi?db=nuccore&id=4159800)    118.2                       0.04
  Ig superfamily receptors               *CLEC4E*     C-type lectin domain family 4, member e                      [AB024717](http://www.ncbi.nlm.nih.gov/entrez/viewer.fcgi?db=nuccore&id=5821285)    180                         0.02
                                         *TREM1*      triggering receptor expressed on myeloid cells 1             [AF241219](http://www.ncbi.nlm.nih.gov/entrez/viewer.fcgi?db=nuccore&id=7800213)    136.4                       0.0063
  Cell proliferation molecules           *CSF3*       colony stimulating factor 3 (granulocyte)                    [AK145177](http://www.ncbi.nlm.nih.gov/entrez/viewer.fcgi?db=nuccore&id=74203201)   114.3                       0.001
                                         *HMGA2*      high mobility group AT-hook 2                                [AC153362](http://www.ncbi.nlm.nih.gov/entrez/viewer.fcgi?db=nuccore&id=66841725)   106.8                       0.002
                                         *G0S2*       G0/G1 switch gene 2                                          [AK003165](http://www.ncbi.nlm.nih.gov/entrez/viewer.fcgi?db=nuccore&id=12833661)   104.7                       0.01
  Neuro-hormone mediators or receptors   *IRG1*       immunoresponsive gene 1                                      [AK036446](http://www.ncbi.nlm.nih.gov/entrez/viewer.fcgi?db=nuccore&id=26331405)   328.9                       0.03
                                         *NPPB*       natriuretic peptide precursor type B                         [AB039044](http://www.ncbi.nlm.nih.gov/entrez/viewer.fcgi?db=nuccore&id=15822833)   204.1                       0.000002
                                         *MRGPRA2*    MAS-related GPR, member A2                                   [AK156116](http://www.ncbi.nlm.nih.gov/entrez/viewer.fcgi?db=nuccore&id=74217732)   202.6                       0.008
                                         *INHBA*      inhibin beta-A                                               [AC154742](http://www.ncbi.nlm.nih.gov/entrez/viewer.fcgi?db=nuccore&id=60543584)   201.9                       0.0003
  Histamine synthesis                    *HDC*        histidine decarboxylase                                      [AB039880](http://www.ncbi.nlm.nih.gov/entrez/viewer.fcgi?db=nuccore&id=7242891)    251.5                       0.03
  Prostaglandin synthesis                *PTGS2*      prostaglandin-endoperoxide synthase 2                        [AC114655](http://www.ncbi.nlm.nih.gov/entrez/viewer.fcgi?db=nuccore&id=51889857)   106.2                       0.004
  Intracellular molecules                *CYP4F18*    cytochrome P450, family 4, subfamily f, polypeptide 18       [AF233647](http://www.ncbi.nlm.nih.gov/entrez/viewer.fcgi?db=nuccore&id=13182971)   164.8                       0.01
                                         *SAMSN1*     SAM domain, SH3 domain and nuclear localization signals, 1   [AC166831](http://www.ncbi.nlm.nih.gov/entrez/viewer.fcgi?db=nuccore&id=73808260)   145.7                       0.002
                                         *PLEK*       pleckstrin                                                   [AF073294](http://www.ncbi.nlm.nih.gov/entrez/viewer.fcgi?db=nuccore&id=8099176)    142.6                       0.003
  Protein transport                      *SLC15A3*    solute carrier family 15, member 3                           [AF121080](http://www.ncbi.nlm.nih.gov/entrez/viewer.fcgi?db=nuccore&id=4580994)    114.2                       0.02

![Distribution of differentially regulated corneal genes. The microarray results compare the number of corneal genes in mouse corneas from *Candida albicans*-infected to the number of corneal genes in mock-infected control mouse corneas. The results are categorized by expression-level differences in twofold increments. A minimum of significant (p≤0.05), twofold upregulation or significant (p≤0.05) twofold down-regulation was required to be charted.](mv-v14-1792-f1){#f1}

Gene expression levels were assigned to general categories based upon known functions of gene products and the number of genes expressing greater than or equal to twofold significant difference (p≤0.05). While functional categories included some down-regulated genes, the number of upregulated genes was consistently more prevalent ([Figure 2](#f2){ref-type="fig"}). Canonical analysis showed that the ratio of significantly upregulated genes within the pathways ranged from 0.13 to 0.34 ([Table 4](#t4){ref-type="table"}). Several signaling pathways included genes that were upregulated fourfold or more ([Appendix 1](http://www.molvis.org/molvis/v14/a211/app-1.pdf)). Similar results were found for selected genes detected by microarray and real-time reverse transcriptase (RT)--PCR analysis ([Table 5](#t5){ref-type="table"}), although *CCR3* expression differed between the infected and mock-infected corneas.

![Differential upregulation and down-regulation of corneal genes. Microarray results compare gene expression levels in mouse corneas from *Candida albicans*-infected compared to corneas from mock-infected controls. The results were assigned to general categories based upon the known functions of the gene products. The number of genes expressing a twofold or greater significant difference (p≤0.05) is plotted for the listed categories. Red bars represent the number of genes significantly down-regulated, and black bars represent the number of genes significantly upregulated.](mv-v14-1792-f2){#f2}

###### Upregulated pathways in *Candida albicans* keratitis compared with mock-infected controls.

  **Signaling pathway**                              **Log** **(p value)**   **Number of genes involved**   **Number upregulated genes**   **Ratio**
  -------------------------------------------------- ----------------------- ------------------------------ ------------------------------ -----------
  Leukocyte extravasation                            16                      191                            44                             0.23
  NF-κβ                                              15.5                    141                            38                             0.27
  Interleukin 10                                     13.2                    68                             23                             0.34
  Interleukin 6                                      12.5                    90                             27                             0.3
  Acute-phase response                               11.3                    171                            36                             0.21
  B cell receptor                                    6.7                     144                            26                             0.18
  Toll-like receptor                                 6.6                     50                             14                             0.28
  Integrin                                           6.1                     188                            30                             0.16
  Natural killer cell                                6                       112                            19                             0.17
  Granulocyte-macrophage colony-stimulating factor   5.8                     63                             15                             0.24
  Transforming growth factor beta                    4.9                     84                             16                             0.19
  Chemokine                                          4.7                     75                             15                             0.2
  Interleukin 2                                      4.5                     52                             12                             0.23
  Insulin-like growth factor 1                       3.8                     94                             15                             0.16
  T cell receptor                                    3.5                     100                            15                             0.15
  Epidermal growth factor                            3                       47                             9                              0.19
  Vascular endothelial growth factor                 3                       93                             13                             0.14
  Interleukin 4                                      3                       69                             11                             0.16
  JAK/STAT                                           2.6                     112                            19                             0.17
  Apoptosis                                          2.5                     62                             8                              0.13

###### Real-time RT-PCR confirmation of microarray.

  **Gene (Symbol)**                             **Microarray**   **Real-time RT-PCR**   **p value**
  --------------------------------------------- ---------------- ---------------------- -------------
  Interleukin 1 beta *(IL-1β)*                  342.4±477.5      378.0±317.4            0.92
  Interleukin *6 (IL-6)*                        376.0±295.4      388.1±318.9            0.96
  Chemokine (C-C) ligand 4 (*CCL4)*             228.7±175.5      200.9±172.2            0.85
  Chemokine (C-C) ligand 7 (*CCL7)*             60.9±51.7        14.9±9.8               0.21
  Chemokine receptor 3 (*CCR3)*                 -6.0±3.5         14.5±4.3               0.004
  Chemokine receptor 5 (*CCR5)*                 1.1±1.1          2.3±0.9                0.20
  Interleukin 23 alpha *(IL-23α)*               9.1±3.3          14.2±9.9               0.44
  Transforming growth factor beta 2 *(TGFβ2)*   1.8±1.0          -1.8±3.7               0.19

Mean fold change ± standard deviation, comparing infected to mock-inoculated control corneas.

Discussion
==========

Fungal keratitis comprises a dynamic interaction between microorganisms and host \[[@r16]\]. Because most mechanisms that mediate the pathogenesis of fungal keratitis have not been elucidated, we explored the global gene expression during *Candida albicans* corneal infection with the use of genetic microarray. To control for the effects of corneal trauma \[[@r17],[@r18]\], we compared corneas having post-traumatic fungal keratitis with scarified controls. At 24 h p.i., approximately 9% of genes were significantly expressed twofold or more and nearly 4% were differentially altered at least fourfold.

Our findings complement previous studies of microbial keratitis. Huang and Hazlett \[[@r11]\] found that approximately 10% of genes changed significantly 24 h after the onset of *Pseudomonas aeruginosa* keratitis in BALB/c and B6 mice. Wang and colleagues \[[@r10]\] exposed heat-killed spores of *Aspergillus fumigatus* to excised pieces of BALB/c mouse cornea and noted that several host genes were substantially upregulated including those encoding interleukin cytokines such as IL-3. These gene expression studies imply that microbial keratitis involves synchronized host processes that affect several aspects of inflammatory and immune responses, intercellular communication, and cellular metabolism.

Toll-like receptors (TLRs) may carry out the initial recognition of fungi at the corneal surface \[[@r19]\]. After binding microbial pathogens \[[@r20],[@r21]\], TLRs can induce intracellular cascades that give rise to inflammatory cytokines. Several members of the TLR family that are expressed on the cornea respond to fungal infection \[[@r22],[@r23]\], and our preliminary analysis suggests that TLR pathways are involved in *Candida albicans* keratitis.

The recruitment of acute inflammatory cells is a key event that immediately follows fungal adherence. Among genes detected by microarray, a quarter of them are involved in signaling leukocyte extravasation, and these genes were significantly upregulated. *Candida albicans* infection triggers chemotactic and other signaling cascades \[[@r22]\] with the nuclear factor-ĸβ pathway having an important role. This transcription factor regulates immune responses to infection and is increased during keratitis \[[@r24]\].

Several mediators of inflammation and wound healing such as metalloproteinases and interleukins are active in the initial events of corneal infection. Genes encoding IL-6 and IL-1β were expressed more than 300 fold during fungal keratitis. Corneal injury results in the upregulation of IL-1β \[[@r18]\], and infection further increases its expression \[[@r25]\]. IL-6 and IL-1β activate neutrophils during *Candida albicans* infection \[[@r26]\]. By validating our microarray results for selected genes that had variable expression patterns, we showed that the early stage of fungal keratitis involves upregulation of proinflammatory interleukins in a pattern similar to that during bacterial keratitis \[[@r11]\]. We also confirmed that TGF-β does not appear to be altered during early fungal infection \[[@r27]\]. While injury induces interleukins and related cytokines, infection enhances the production of selected mediators of acute inflammation.

Our studies of fungal keratitis are consistent with other models of *Candida albicans* infection. Expression patterns of genes coding for IL-6 and chemokine receptors markedly increase soon after the onset of *Candida albicans* exposure \[[@r27]\], and this increase likely contributes to the recruitment and influx of leukocytes into the infected cornea. Histopathological evidence also indicates that corneal inflammation during the incipient stage of *Candida albicans* keratitis is a manifestation of the innate immune response \[[@r13]\].

In parallel with pathways promoting ulcerative keratitis, the cornea has anti-inflammatory mechanisms for inhibiting NF-ĸβ activity and dampening the effects of inflammatory mediators. Although increased during bacterial keratitis, IL-10 was not significantly altered 24 h after corneal inoculation with yeasts, possibly because of a different kinetic profile. However, approximately one-third of genes involved in IL-10 signaling were significantly upregulated during *Candida albicans* keratitis. Other inflammatory suppressors such as suppressor of cytokine signaling protein-3 were also upregulated.

Pathways of immune recognition may also be activated by fungal infection. We confirmed that IL-23 increases during *Candida albicans* keratitis \[[@r27]\]. Expression of this T-cell regulatory molecule suggests that adaptive immunity may be involved in candidiasis, although to a lesser degree than innate immune reactions \[[@r28]\].

Our study provides evidence for a likely scenario of molecular events during early fungal keratitis. Soon after corneal surface injury and exposure to viable fungi, fungal components are recognized by host receptors such as lectins and toll-like receptors. Binding by ligands induces intracellular cascades that activate NF-ĸβ, which, in turn, upregulates genes responsible for inflammatory responses. Corneal levels of interleukins and other cytokines rapidly increase. Neutrophils and macrophages are recruited toward the site of infection, helping to kill fungi but releasing chemokines that contribute to corneal ulceration and neovascularization.

In summary, gene microarray analysis is a useful means for understanding the molecular biology of ocular inflammatory disease. *Candida albicans* keratitis involves the induction of genes encoding several interrelated pathways, and this investigation provides insight into the pivotal reactions during the onset of fungal keratitis. Characterizing this coordinated sequence of events can provide insight into the pathogenesis of fungal keratitis that will open up new opportunities for therapeutic interventions.

To access the data, click or select the words "[Appendix 1](http://www.molvis.org/molvis/v14/a211/app-1.pdf)". This will initiate the download of a (pdf) archive that contains the file.

This work was supported by the Sid W. Richardson Foundation (Fort Worth, TX), the Research to Prevent Blindness Inc. (New York, NY), and core grant EY02520 from the National Eye Institute (Bethesda, MD).
